Pioglitazone on Heart Failure in Type-2 Diabetes Mellitus Participants

Abroad (travel likely)RecruitingPHASE4

Conditions

Type 2 Diabetes Mellitus in Obese · Heart Failure With Preserved Ejection Fraction

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Texas Diabetes Institute/UH, San Antonio, Texas, United States
Contact: Study coordinator (Ralph DeFronzo, MD) · defronzo@uthscsa.edu · 210-358-7200
Contact: Study coordinator (Sivaram Neppala, MD) · neppalas@uthscsa.edu · 210-358-7200
Contact: Principal Investigator (Ralph DeFronzo, MD)
Sivaram Neppala, MD (Sub-investigator)

Study leads

Ralph A DeFronzo, MD
Principal Investigator
University of Texas

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes

Obesity or Overweight · Type 2 Diabetes Mellitus

Abroad (travel likely)RecruitingPHASE3

Guntersville, United States · Tucson, United States

AMAZE 2: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight

Diabetes Mellitus · Overweight · Obesity

Abroad (travel likely)RecruitingPHASE3

Birmingham, United States · Escondido, United States

A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide

Type 2 Diabetes

Abroad (travel likely)RecruitingPHASE2

Phoenix, United States · Santa Ana, United States

Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents

Type 2 Diabetes · Insulin Resistance · Obesity

Abroad (travel likely)Recruiting

Ann Arbor, United States